Boehringer Ingelheim USA Corporation

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Bioavailability of BIBR 963 ZW After 50 mg of BIBR 1048 MS With and Without of Pantoprazole in Healthy Subjects

Phase 1

Completed

Conditions: Healthy

Interventions: Drug: BIBR 1048 MS Capsule D
Drug: BIBR 1048 MS tartaric acid solution
Drug: BIBR 1048 MS Capsule C
Drug: BIBR 1048 MS Capsule A
Drug: BIBR 1048 MS Capsule B
Drug: Pantoprazole

First Posted Date: 2014-06-23

Last Posted Date: 2014-06-23

Lead Sponsor: Boehringer Ingelheim

Target Recruit Count: 16

Registration Number: NCT02170896

Relative Bioavailability of Dabigatran and Atorvastatin in Healthy Male and Female Volunteers

Phase 1

Completed

Conditions: Healthy

Interventions: Drug: Dabigatran
Drug: Atorvastatin

First Posted Date: 2014-06-23

Last Posted Date: 2018-08-31

Lead Sponsor: Boehringer Ingelheim

Target Recruit Count: 24

Registration Number: NCT02171039

BIBR 1048 in the Prevention of Venous Thromboembolism in Patients Undergoing Primary Elective Total Hip Replacement Surgery

Phase 2

Completed

Conditions: Venous Thromboembolism

Interventions: Drug: BIBR 1048

First Posted Date: 2014-06-23

Last Posted Date: 2018-08-31

Lead Sponsor: Boehringer Ingelheim

Target Recruit Count: 289

Registration Number: NCT02170701

Safety, Pharmacokinetics and Pharmacodynamics of BIBR 1048 MS Capsule in Healthy Male Subjects of Japanese and Caucasian Origin

Phase 1

Completed

Conditions: Healthy

Interventions: Drug: BIBR 1048 MS low dose
Drug: BIBR 1048 MS medium dose
Drug: BIBR 1048 MS high dose

First Posted Date: 2014-06-23

Last Posted Date: 2018-08-31

Lead Sponsor: Boehringer Ingelheim

Target Recruit Count: 42

Registration Number: NCT02170909

Safety, Pharmacokinetics and Pharmacodynamics After Single Rising Oral Doses of BIBR 1048 MS as Capsules in Healthy Subjects of Japanese and Caucasian Origin

Phase 1

Completed

Conditions: Healthy

Interventions: Drug: BIBR 1048 MS
Drug: Placebo of BIBR 1048 MS

First Posted Date: 2014-06-23

Last Posted Date: 2018-08-31

Lead Sponsor: Boehringer Ingelheim

Target Recruit Count: 40

Registration Number: NCT02170844

Bioavailability of BIBR 953 ZW in Healthy Subjects

Phase 1

Completed

Conditions: Healthy

Interventions: Drug: BIBR 1048 low1
Drug: BIBR 1048 low2
Drug: BIBR 1048 medium
Drug: BIBR 1048 high
Drug: Pantoprazole

First Posted Date: 2014-06-23

Last Posted Date: 2014-06-23

Lead Sponsor: Boehringer Ingelheim

Target Recruit Count: 48

Registration Number: NCT02170766

Bioavailability of Dabigatran and Amiodarone After Multiple Oral Administrations of Dabigatran Etexilate With or Without Amiodarone as Single Dose in Healthy Male and Female Volunteers

Phase 1

Completed

Conditions: Healthy

Interventions: Drug: Dabigatran etexilate
Drug: Amiodarone

First Posted Date: 2014-06-23

Last Posted Date: 2014-06-23

Lead Sponsor: Boehringer Ingelheim

Target Recruit Count: 24

Registration Number: NCT02171026

Bioavailability of BIBR 953 ZW After BIBR 1048 (Oral Pro-drug of BIBR 953 ZW) Administered as Hydroxypropyl Methylcellulose (HPMC) Polymorph II Capsule Relative to HPMC Polymorph I Capsule in Healthy Subjects.

Phase 1

Completed

Conditions: Healthy

Interventions: Drug: BIBR 1048 MS polymorph I
Drug: BIBR 1048 MS polymorph II

First Posted Date: 2014-06-23

Last Posted Date: 2014-06-23

Lead Sponsor: Boehringer Ingelheim

Target Recruit Count: 28

Registration Number: NCT02170974

Assessment of Safety, Pharmacokinetics and the Effect of BIBR 1048 MS on Coagulation Parameters in Healthy Volunteer Subjects

Phase 1

Completed

Conditions: Healthy

Interventions: Drug: BIBR 1048 MS - low dose
Drug: BIBR 1048 MS + Pantoprazole
Drug: BIBR 1048 MS - high dose

First Posted Date: 2014-06-23

Last Posted Date: 2014-06-23

Lead Sponsor: Boehringer Ingelheim

Target Recruit Count: 26

Registration Number: NCT02170740

Bioavailability of BIBR 1048 MS With and Without Pantoprazole Under Influence of Food in Healthy Subjects

Phase 1

Completed

Conditions: Healthy

Interventions: Drug: BIBR 1048 MS
Drug: Pantoprazole

First Posted Date: 2014-06-23

Last Posted Date: 2014-06-23

Lead Sponsor: Boehringer Ingelheim

Target Recruit Count: 18

Registration Number: NCT02170610

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy